(1R,2S)-4-(dimethylamino)-1-(2-methoxy-6-phenylpyridin-3-yl)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol

ID: ALA5170424

Chembl Id: CHEMBL5170424

PubChem CID: 168268967

Max Phase: Preclinical

Molecular Formula: C34H34N2O2

Molecular Weight: 502.66

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1nc(-c2ccccc2)ccc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12

Standard InChI:  InChI=1S/C34H34N2O2/c1-36(2)24-23-34(37,30-20-12-18-25-13-10-11-19-28(25)30)32(27-16-8-5-9-17-27)29-21-22-31(35-33(29)38-3)26-14-6-4-7-15-26/h4-22,32,37H,23-24H2,1-3H3/t32-,34-/m1/s1

Standard InChI Key:  VTBSOVMFNXLXAW-ZFEZZJPFSA-N

Alternative Forms

  1. Parent:

    ALA5170424

    ---

Associated Targets(non-human)

Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium peregrinum (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis variant bovis (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 502.66Molecular Weight (Monoisotopic): 502.2620AlogP: 6.88#Rotatable Bonds: 9
Polar Surface Area: 45.59Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.61CX Basic pKa: 8.91CX LogP: 7.02CX LogD: 5.50
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.24Np Likeness Score: -0.48

References

1. Huang Z, Luo W, Xu D, Guo F, Yang M, Zhu Y, Shen L, Chen S, Tang D, Li L, Li Y, Wang B, Franzblau SG, Ding CZ..  (2022)  Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.,  71  [PMID:35636648] [10.1016/j.bmcl.2022.128824]

Source